Research and analysis

Valproate: Managing reproductive risks in male patients under 55

Public Assessment Report on managing reproductive risks in male patients under 55 taking valproate.

From:
Medicines and Healthcare products Regulatory Agency
Published
13 February 2025

Documents

PDF, 392 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the current risk minimisation measures in place for men under 55 years taking valproate and the advice of the CHM on whether further regulatory action is appropriate.

Updates to this page

Published 13 February 2025

Sign up for emails or print this page